Multiplex rapid immunoassay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from respiratory specimens. Delivers results in approximately 15 minutes, enabling quick clinical decision-making in point-of-care and laboratory settings. Single-use test cartridge with integrated sam...
Manufactured by
CorDx
Singapore, United States
CorDx is a global diagnostics company that develops, manufactures, and supplies innovative rapid diagnostic testing solutions for families and healthcare providers worldwide. The company operates with a vertically integrated supply chain and manufacturing footprints in the US and internationally, focusing on delivering rapid, accurate, and reliable diagnostic products. CorDx is part of CorDx Union, a biotechnology organization serving healthcare industries and over a billion users in more than 170 countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Advin Biotech, Inc.
United States · 1 relevant product
SureScreen Diagnostics Limited
United Kingdom · 3 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 2 relevant products
71 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 118 closest product alternatives
Advin Biotech, Inc. · United States
Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
115 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products